Cancer test kit PNACIamp™

for RT-PCR

Mutations of IDH1 (isocitrate dehydrogenase 1,IDH1) can be found in glioblastoma and myeloproliferative neoplasm. Detection of IDH1mutations can be a positive predictor of a prognosis and a molecular marker for glioblastoma patients. On the other hand, it is reported that IDH1 mutations correlate with poor prognosis in myeloproliferative neoplasm. PNAClamp™ IDH1 Mutation Detection Kit is a new member of somatic mutation detection kits utilizing PNA-mediated PCR Clamping technology, and can help patients choose the right medicine and monitor prognosis. FEATURES High sensitivity and specificity even with small amount of DNA (1% LOD with 10 ng wild/mutant type mixed DNA) Real-Time PCR based ready-to-use kit Short running time (within 3 hours)